A Phase I Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study is a randomized, double-blind, placebo-controlled, dose-escalation phase I clinical trial. This study consists of two parts: the single-dose escalation study (SAD) in healthy subjects and the multiple-dose escalation study (MAD) in obese patients.
Epistemonikos ID: 9074922866c6cf8097e2821df005821385e2d638
First added on: Dec 16, 2025